Protecting those who protect us: Ensuring vaccinations for health workers on the frontlines
It happened in seconds. The doors of the health facility flew open. A young man was rushed in, barely breathing, his family screaming behind him. Blood was everywhere, on the floor, his clothes, the hands of those trying to steady him. And without hesitation, the health workers moved towards him instinctively. There were no questions asked, no moments wasted, just an instinctive rush to save a life, guided by their training and dedication.
Later, we learned it was a suicide attempt. He had ingested rat poison. But in that critical moment, nothing else mattered to the health workers fighting to stabilize him. There was no time to ask questions, assess risks, or think of their own safety.
As I stood there, watching, one thought wouldn't leave me: What if this had been something else? What if the blood, later discovered to be palm oil, carried something more? What if the man was unknowingly infected with mpox, or another infectious disease spreading quietly through communities?
This is the daily reality faced by health workers across Sierra Leone. They are the first to respond, the first to make contact, and the first to put themselves at risk, often without knowing what dangers they might encounter. When hesitation could lead to death, their instinct to save lives overrides every fear. They are the backbone of our health system, yet they remain dangerously exposed.
But who ensures their safety? In Sierra Leone, mpox is not a distant threat. Since the first case was reported earlier this year, the virus has spread to all 16 districts. Thousands have been infected. Health workers are on the frontlines, not only caring for known cases, but often unknowingly exposed to patients who may not yet show symptoms.
Mpox can spread through close skin to skin contact, bodily fluids, blood. The very acts of care, cleaning wounds, delivering babies, providing urgent treatment carry huge risks.
Dr. James Squire, the National Incident Manager, summed it up clearly: 'Our health workers are our greatest asset. If we lose them, we lose everything.'
We have lived this before, and the painful memory still lingers. During the Ebola crisis, several health workers died. The loss was catastrophic, not just for families and communities, but for the entire health system that was already so fragile. We cannot afford to allow history to repeat itself.
This time, we have a tool, we didn't have then: vaccines. In a remarkable show of solidarity, the Democratic Republic of Congo (DRC), a nation familiar with the challenges of mpox and Ebola outbreaks extended a helping hand. With the coordination and support of the World Health Organization (WHO), the DRC generously donated 75,000 doses of mpox vaccine to Sierra Leone.
Fatmata, a health worker at a district hospital, expressed it poignantly: 'We rush into danger without hesitation. But at the same time, we have loved ones waiting for us back home. We want to continue serving, but we also need to feel secure.'
When health workers are vaccinated, entire communities are safer. Economies thrive. And outbreaks are contained before they spiral. The ripple effect of protecting one health worker reaches far beyond the four walls of a health facility.
Now is the moment. Every health worker in Sierra Leone - nurse, doctor, cleaner, ambulance driver, laboratory technician - must be vaccinated. No one who steps into a space of care should be left unprotected.
Dr George Ameh, WHO Representative in Sierra Leone, emphasized: 'We are at a turning point. The vaccines have arrived. Now we must act. Every health worker vaccinated is one pillar strengthening the entire health system. This is one of the tools we have to halt the outbreak.'
The health workers who rushed toward that patient didn't stop to ask whether it was safe. They acted because that's what they do. They show up, every day, in every crisis. But showing up should not cost them their lives. This time, we have a chance to protect them before they pay that price.
In addition to pre-exposure vaccination against mpox and post exposure management, heath workers and all frontline workers should always observe strict infection prevention and control procedures and use personal protective equipment (PPEs) when handling suspected and confirmed patients.
Distributed by APO Group on behalf of World Health Organization - Sierra Leone.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
a day ago
- Zawya
Qatar's health expenditure to surge 14% by 2029
DOHA: Qatar's healthcare industry is poised for rapid expansion, with total health spending projected to grow at a compound annual growth rate (CAGR) of 14 percent by 2029, reaching $11.5bn (QR42bn), according to a recent report by Fitch Solutions. Health experts note that this growth would make Qatar the third-largest healthcare market in the Gulf Cooperation Council (GCC) and the tenth-largest in the Middle East and North Africa (MENA) region. Despite these impressive figures, analysts at Fitch Solutions stress that Qatar's overall market opportunities are challenging compared to other regional players. This is primarily due to the country's small population size and modest short-term economic growth prospects. 'The numbers show a healthy trajectory, but we must be careful not to confuse high growth rates with large-scale opportunity,' said Dr. Lisa Kurian, a Doha-based public health specialist. 'Qatar's small population means we are working with a narrower base, even if spending per capita is among the highest in the region.' Government investment, driven by the National Development Strategy 2024–2030, continues to underpin the growth in public health expenditure. Meanwhile, the private sector is benefiting from strong per capita health spending and ongoing public-private partnerships. 'Qatar has done well to encourage private sector involvement without compromising public oversight,' said Dr. Kurian adding that projects like Surgi Art Hospital are proof that collaboration is driving innovation in patient care. On the other hand, digital transformation is also playing a key role in ensuring efficient healthcare delivery. Government-backed initiatives like the Smart Programme (TASMU) aim to leverage big data, AI, and integrated electronic health records to streamline services and prevent resource bottlenecks. In July 2024, the government signed an agreement with AI firm Lunit to introduce AI-powered breast cancer screening tools across primary health centres—an initiative expected to enhance early detection and reduce long-term costs. 'Investing in AI for diagnostics is not just about innovation—it's about sustainability. Early diagnosis means better outcomes and lower treatment costs, which is critical for long-term health system viability, the medical expert said. She also emphasised that 'Technology cannot replace people. Without well-trained, adequately supported staff, even the most advanced tools will fall short of their potential.' As Qatar positions itself as a leader in high-value healthcare within the region, striking the right balance between innovation, infrastructure, and human capital will be critical. Additionally, researchers highlight that the next phase of development must focus on systemic resilience, ensuring that digital health tools, regulatory frameworks, and a capable workforce work together cohesively to deliver quality care for a changing population. With its strong fiscal position, high per capita income, and strategic vision for healthcare advancement, Qatar is also becoming an increasingly attractive destination for international healthcare companies, investors, and research institutions. © Dar Al Sharq Press, Printing and Distribution. All Rights Reserved. Provided by SyndiGate Media Inc. (

Zawya
a day ago
- Zawya
World Bank Approves Health Resilience Project to Protect Lives and Strengthen Emergency Response in Mozambique
The World Bank has approved the Mozambique Health Emergency Preparedness, Response and Resilience Project, an initiative to strengthen the health system's ability to deliver essential services consistently and equitably. The project targets underserved and climate-vulnerable areas by investing in human resources, infrastructure, and systems that ensure continuity of care during emergencies. This project is part of a regional p rogram to strengthen health security across Eastern and Southern Africa. Mozambique faces frequent floods, cyclones, disease outbreaks, and other emergencies that disrupt health services and put lives at risk. Many communities lack sufficient and trained health workers, access to essential medicines, and the tools to detect and respond quickly to crises. The project seeks to address these gaps by: Strengthening the health workforce capacity, particularly in high-risk areas, by improving recruitment, training, and retention systems; Improving pharmaceutical supply chains by supporting the regulatory agency in bringing more transparency and speed to procurement processes, lowering and standardizing prices of health commodities to ensure access to medicines, particularly during crises; and Enhancing disease surveillance and laboratory capacity to improve early warning and response systems to quickly detect and respond to health emergencies like cholera outbreaks or heatwaves. The project also supports the development of climate-adaptive infrastructure and emergency preparedness plans, recognizing the growing health risks posed by climate change. ' Mozambique is already experiencing the health impacts of shocks and emergencies,' noted Luc Lecuit, World Bank Acting Division Director in Mozambique. 'The program supports the government's efforts to strengthen core health service delivery by investing in preparedness and resilience, ensuring services remain operational during floods, storms, and epidemics.' Financed through a $201 million grant from the International Development Association (IDA)*, the initiative will be implemented over five years, concluding in September 2030. 'By prioritizing practical investments in the foundational pillars of the health sector, the Government of Mozambique is driving greater efficiency across the system and strengthening its emergency response capacity to protect lives,' said João Pires, World Bank Senior Health Specialist and Task Team Leader. 'These efforts are paving the way for bold reforms to ensure the health system remains resilient and responsive, even under pressure.' In parallel, the World Bank, together with other development partners, is increasing its support to the Mozambique health sector through a $63.7 million top-up to the ongoing District and Community Health Services Revitalization Project. This additional financing—comprising $8.7 million from IDA, $5 million from the Global Financing Facility, and $50 million from a multi-donor trust fund supported by Canada, the United Kingdom, and Ireland—will expand the project's impact across the most vulnerable 63 districts of Mozambique. The operation focuses on improving access to quality primary health care, particularly for women, children, and adolescents, and strengthening service delivery at the district and community levels. Both projects align with the forthcoming Mozambique's Health Sector Strategic Plan (PESS, 2025-2034) (PESS 2020–2024) and the National Adaptation Plan (2023), and complement regional efforts to strengthen health security across Eastern and Southern Africa. Distributed by APO Group on behalf of The World Bank Group.


Zawya
2 days ago
- Zawya
Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
Understanding Asian Cancers and Diabetes Through an Asian Lens SINGAPORE - Media OutReach Newswire - 27 June 2025 - Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health policy. Despite global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction models. Imelda Tanoto, Member of the Board of Trustees, Tanoto Foundation said: "Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region." Tackling Asian-Prevalent Cancers Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia: Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region These cancers are devastating but remain poorly understood because most research has focused on Western populations," said Dr Chan. "By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients." A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and collaboration. Unmasking Diabetes Risk in Young Singaporeans The second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal weight. Unlike traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour. "Many young Asians with diabetes don't fit the usual risk profile. They're lean, active, and often overlooked by current screening models," said Dr Gardner. "We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and beyond." Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term complications. Singapore as a Hub for Medical Research Advancement In addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private partnerships. Imelda Tanoto added: "We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting." This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better healthspans. Hashtag: #TanotoFoundation The issuer is solely responsible for the content of this announcement. About Tanoto Foundation At Tanoto Foundation, we unlock human potential, help communities thrive, and create lasting impact. Founded in 1981 by Sukanto Tanoto and Tinah Bingei Tanoto, we are an independent family foundation that believes in providing every person with the opportunity to realize his or her full potential. To do so, we catalyse systems change in education and healthcare. Our approach is impact-first, collaborative, and evidence-based. We invest for the long term and strive to develop leaders who can drive sustained, positive outcomes. More information is available at Tanoto Foundation